Abstract
Background
Giant cell arteritis (GCA) is a systemic granulomatous vasculitis, primarily affecting medium-large arteries. It has a predilection for the aorta and its major branches, including the carotid and vertebral arteries. Ophthalmic artery involvement frequently leads to irreversible visual loss, and therefore GCA is one of the few true ophthalmic emergencies. GCA, although classified as a large vessel vasculitis, is known to affect smaller-sized vessels, resulting in a multiplicity of signs in the eye, some of which are often missed.
Purpose
We set out to highlight some of the less frequently observed clinical signs, which may provide clues to clinically diagnosing GCA in patients presenting with non-classical features and inconclusive inflammatory markers.
Methods
We review the literature and describe the diverse ocular features and some of the systemic findings that can be associated with GCA.
Results
Although the most common ocular manifestation of GCA is anterior ischaemic optic neuropathy, the clinical presentation of GCA can vary dramatically. In the absence of obvious ocular involvement, more subtle ophthalmic signs of anterior segment ischaemia, such as hypotony and anisocoria, may be present at the time of initial clinical examination.
Conclusion
There are no specific biomarkers for disease to date; therefore, pertinent history and clinical examination can guide towards diagnosis in the acute setting. The diagnostic process is not always straightforward, yet appropriate and prompt diagnosis is critical to enable timely intervention and prevent significant morbidity.
Similar content being viewed by others
References
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11. doi:10.1002/art.37715
Haugeberg G, Irgens KA, Thomsen RS (2003) No major differences in incidence of temporal arteritis in northern and western Norway compared with reports from southern Norway. Scand J Rheumatol 32(5):318–319
De Smit E, Palmer AJ, Hewitt AW (2015) Projected worldwide disease burden from giant cell arteritis by 2050. J Rheumatol 42(1):119–125. doi:10.3899/jrheum.140318
Serrano A, Carmona FD, Castaneda S, Solans R, Hernandez-Rodriguez J, Cid MC et al (2013) Evidence of association of the NLRP1 gene with giant cell arteritis. Ann Rheum Dis 72(4):628–630. doi:10.1136/annrheumdis-2012-202609
Carmona FD, Gonzalez-Gay MA, Martin J (2014) Genetic component of giant cell arteritis. Rheumatology (Oxford) 53(1):6–18. doi:10.1093/rheumatology/ket231
Mackie SL, Taylor JC, Haroon-Rashid L, Martin S, Dasgupta B, Gough A et al (2015) Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation. Arthritis Res Ther 17:195. doi:10.1186/s13075-015-0692-4
Carmona FD, Mackie SL, Martin JE, Taylor JC, Vaglio A, Eyre S et al (2015) A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet 96(4):565–580. doi:10.1016/j.ajhg.2015.02.009
Rahman W, Rahman FZ (2005) Giant cell (temporal) arteritis: an overview and update. Surv Ophthalmol 50(5):415–428. doi:10.1016/j.survophthal.2005.06.011
Duhaut P, Bosshard S, Ducroix JP (2004) Is giant cell arteritis an infectious disease? Biological and epidemiological evidence. Presse Med 33(19 Pt 2):1403–1408
Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL et al (2015) Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol 72(11):1281–1287. doi:10.1001/jamaneurol.2015.2101
Rodriguez-Pla A, Stone JH (2006) Vasculitis and systemic infections. Curr Opin Rheumatol 18(1):39–47
Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347(4):261–271. doi:10.1056/NEJMra011913
Paraskevas KI, Boumpas DT, Vrentzos GE, Mikhailidis DP (2007) Oral and ocular/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequences. Clin Rheumatol 26(7):1044–1048. doi:10.1007/s10067-006-0493-x
Borchers AT, Gershwin ME (2012) Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 11(6–7):A544–A554. doi:10.1016/j.autrev.2012.01.003
Salvarani C, Cantini F, Hunder GG (2008) Polymyalgia rheumatica and giant-cell arteritis. Lancet 372(9634):234–245. doi:10.1016/S0140-6736(08)61077-6
Borg FA, Salter VL, Dasgupta B (2008) Neuro-ophthalmic complications in giant cell arteritis. Curr Allergy Asthma Rep 8(4):323–330
Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125(4):509–520
Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G et al (2005) Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum 53(2):293–297. doi:10.1002/art.21075
Salvarani C, Pipitone N, Versari A, Hunder GG (2012) Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 8(9):509–521. doi:10.1038/nrrheum.2012.97
Meadows SP (1966) Temporal or giant cell arteritis. Proc R Soc Med 59(4):329–334
Carroll SC, Gaskin BJ, Danesh-Meyer HV (2006) Giant cell arteritis. Clin Experiment Ophthalmol 34(2):159–173. doi:10.1111/j.1442-9071.2006.01186.x, quiz 194
Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65(8):1093–1098. doi:10.1136/ard.2005.046912
Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE (2003) Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 33(1):38–48. doi:10.1053/sarh.2002.50025
Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W (1998) Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 25(11):2140–2145
Rooney PJ, Rooney J, Balint G, Balint P (2014) Polymyalgia rheumatica: 125 years of progress? Scott Med J 59(4):220–228. doi:10.1177/0036933014548144
Hayreh SS, Podhajsky PA, Zimmerman B (1998) Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 125(4):521–526, Erratum appears in Am J Ophthalmol 1998 Jun;125(6):893
Hollenhorst RW (1967) Effect of posture on retinal ischemia from temporal arteritis. Arch Ophthalmol 78(5):569–577
Danesh-Meyer H, Savino PJ, Gamble GG (2005) Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology 112(6):1098–1103. doi:10.1016/j.ophtha.2005.01.036
Mehler MF, Rabinowich L (1988) The clinical neuro-ophthalmologic spectrum of temporal arteritis. Am J Med 85(6):839–844
Liu NH, LaBree LD, Feldon SE, Rao NA (2001) The epidemiology of giant cell arteritis : a 12-year retrospective study. Ophthalmology 108(6):1145–1149
Singh AG, Kermani TA, Crowson CS, Weyand CM, Matteson EL, Warrington KJ (2015) Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. J Rheumatol 42(2):309–315. doi:10.3899/jrheum.140188
Hayreh SS, Zimmerman B, Kardon RH (2002) Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand 80(4):355–367
Kopsachilis N, Pefkianaki M, Marinescu A, Sivaprasad S (2013) Giant cell arteritis presenting as choroidal infarction. Case Rep Ophthalmol Med 2013:597398. doi:10.1155/2013/597398
Huna-Baron R, Mizrachi IB, Glovinsky Y (2006) Intraocular pressure is low in eyes with giant cell arteritis. J Neuroophthalmol 26(4):273–275. doi:10.1097/01.wno.0000249332.95722.22
Reddi S, Vollbracht S (2013) Giant cell arteritis associated with orbital pseudotumor. Headache 53(9):1488–1489. doi:10.1111/head.12100
Cavallini GM, Volante V, Bigliardi MC, Mascia MT, Forlini M (2014) Bilateral posterior scleritis as a presenting manifestation of giant cell arteritis: A case report. Can J Ophthalmol 49(6):e141–e143. doi:10.1016/j.jcjo.2014.08.015
Papathanassiou M, Elezoglu A, Nikita E, Theodossiadis PG, Vergados I (2009) A rare case of peripheral ulcerative keratitis in temporal arteritis. Eur J Ophthalmol 19(5):866–869
Schmidt D (2005) Ocular ichemia syndrome — a malignant course of giant cell arteritis. Eur J Med Res 10(6):233–242
Hayreh SS (2004) Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye (Lond) 18(11):1188–1206. doi:10.1038/sj.eye.6701562
Gupta PK, Asrani S, Freedman SF, El-Dairi M, Bhatti MT (2011) Differentiating glaucomatous from non-glaucomatous optic nerve cupping by optical coherence tomography. Open Neurol J 5:1–7. doi:10.2174/1874205X01105010001
Lemos J, Eggenberger E (2015) Neuro-ophthalmological emergencies. Neurohospitalist 5(4):223–233. doi:10.1177/1941874415583117
Srinivasan S, Moorthy S, Sreekumar K, Kulkarni C (2012) Diffusion-weighted MRI in acute posterior ischemic optic neuropathy. Indian J Radiol Imaging 22(2):106–107. doi:10.4103/0971-3026.101082
Crompton MR (1959) The visual changes in temporal (giant-cell) arteritis. Report of a case with autopsy findings. Brain 82:377–390
Johnson MC, Lee AG (2008) Giant cell arteritis presenting with cotton wool spots. Semin Ophthalmol 23(3):141–142
Hayreh SS (2004) Posterior ciliary artery circulation in health and disease: the Weisenfeld lecture. Invest Ophthalmol Vis Sci 45(3):749–757, 748
Schmidt D (2008) The mystery of cotton-wool spots — a review of recent and historical descriptions. Eur J Med Res 13(6):231–266
McLeod D (2005) Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts. Br J Ophthalmol 89(2):229–237. doi:10.1136/bjo.2004.058347
Parsons-Smith G (1979) Ocular complications of temporal arteritis. Br Med J 1(6178):1625–1626
De Smit E, O’Sullivan E (2013) Cotton-wool spots in giant cell arteritis. CMAJ 185(9):796. doi:10.1503/cmaj.120540
Samson M, Augustin P, Verdure L, Fondimare A (1974) A case of Horton’s disease with extensive necrosis at the cephalic level. Revue OtoneuroOphtalmologie 46(2):183–188
Winter BJ, Cryer TH, Hameroff SB (1977) Anterior segment ischemia in temporal arteritis. South Med J 70(12):1479–1481
Cucera A, Lang GE (2011) Rare ocular manifestation of Horton’s disease. Klin Monatsbl Augenheilkd 228(7):631–636. doi:10.1055/s-0029-1246036
McKillop E, Tejwani D, Weir C, Jay J (2006) Anterior segment ischaemia with giant cell arteritis. Can J Ophthalmol 41(2):201–203. doi:10.1139/I06-009
Slemp SN, Martin SE, Burgett RA, Hattab EM (2014) Giant cell arteritis presenting with uveitis. Ocul Immunol Inflamm 22(5):391–393. doi:10.3109/09273948.2013.849351
Horven I (1973) Dynamic tonometry. V. Further studies of the corneal indentation pulse in temporal arteritis. Acta Ophthalmologica 51(3):353–366
Daicker B, Keller HH (1971) Giant cell arteritis with endocular spreading and hypotonia bulbi dolorosa. A clinico-pathological report. Klin Monatsbl Augenheilkd 158(3):358–372
Radda TM, Bardach H, Riss B (1981) Acute ocular hypotony. A rare complication of temporal arteritis. Ophthalmologica 182(3):148–152
Bayar SA, Gokmen O, Pinarci EY, Altinors DD, Gedik S (2012) Corneal endothelial decompansation and ocular hypotony in a case with temporal arteritis. J Neuroophthalmol 32(4):385. doi:10.1097/WNO.0b013e31827285cf
Prasad S, Baccon J, Galetta SL (2009) Mydriatic pupil in giant cell arteritis. J Neurol Sci 284(1–2):196–197. doi:10.1016/j.jns.2009.04.027
Foroozan R, Buono LM, Savino PJ, Sergott RC (2003) Tonic pupils from giant cell arteritis. Br J Ophthalmol 87(4):510–512
Eliskova M (1973) Blood vessels of the ciliary ganglion in man. Br J Ophthalmol 57(10):766–772
Currie J, Lessell S (1984) Tonic pupil with giant cell arteritis. Br J Ophthalmol 68(2):135–138
Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A et al (2000) Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 79(5):283–292
Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A et al (1998) Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 41(1):26–32. doi:10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0
Wilkinson IM, Russell RW (1972) Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 27(5):378–391
Davis RH, Daroff RB, Hoyt WF (1968) Tonic pupil after temporal arteritis. Lancet 1(7546):822
Barricks ME, Traviesa DB, Glaser JS, Levy IS (1977) Ophthalmoplegia in cranial arteritis. Brain 100(2):209–221
Killer HE, Holtz DJ, Kaiser HJ, Laeng RH (2000) Diplopia, ptosis, and hepatitis as presenting signs and symptoms of giant cell arteritis. Br J Ophthalmol 84(11):1319–1320
Wagener HP, Hollenhorst RW (1957) The ocular lesions of temporal arteritis. Trans Am Ophthalmol Soc 55:249–273; discussion 269–273
Laidlaw DA, Smith PE, Hudgson P (1999) Orbital pseudotumour secondary to giant cell arteritis: an unreported condition. BMJ 300(6727):784
Schmidt D, Ness T (2009) Ocular findings and differential diagnoses in giant cell arteritis (Arteriitis cranialis). Z Rheumatol 68(2):117–123. doi:10.1007/s00393-008-0376-4
Casson RJ, Fleming FK, Shaikh A, James B (2001) Bilateral ocular ischemic syndrome secondary to giant cell arteritis. Arch Ophthalmol 119(2):306–307
Hwang JM, Girkin CA, Perry JD, Lai JC, Miller NR, Hellmann DB (1999) Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. Am J Ophthalmol 127(1):102–104
Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M et al (1998) Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41(8):1497–1504. doi:10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z
Weyand CM, Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349(2):160–169. doi:10.1056/NEJMra022694
Reich KA, Giansiracusa DF, Strongwater SL (1990) Neurologic manifestations of giant cell arteritis. Am J Med 89(1):67–72
Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Diaz MJ, Vazquez-Trinanes MC et al (2009) Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine (Baltimore) 88(4):227–235. doi:10.1097/MD.0b013e3181af4518
Salvarani C, Giannini C, Miller DV, Hunder G (2006) Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 55(6):985–989. doi:10.1002/art.22359
Alba MA, Espigol-Frigole G, Prieto-Gonzalez S, Tavera-Bahillo I, Garcia-Martinez A, Butjosa M et al (2011) Central nervous system vasculitis: still more questions than answers. Curr Neuropharmacol 9(3):437–448
Tang V, Fantaneanu T, Chakraborty S, Patel V, Dowlatshahi D (2012) Intracranial non-occlusive thrombus and multiple strokes in giant cell arteritis. Can J Neurol Sci 39(1):116–117
Solans-Laque R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Tarres M (2008) Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature. Medicine (Baltimore) 87(6):335–344. doi:10.1097/MD.0b013e3181908e96
Chhetri SK, Bindman D, Joseph J, Mathur S, Shaunak S (2015) Fulminant acephalgic giant cell arteritis with basal cerebral artery occlusion: a radiological and clinico-pathological study. Cephalalgia 35(12):1133–1136. doi:10.1177/0333102415570345
Caselli RJ (1990) Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia. Neurology 40(5):753–755
Pujades-Rodriguez M, Duyx B, Thomas SL, Stogiannis D, Smeeth L, Hemingway H (2016) Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases. Heart 102(5):383–389. doi:10.1136/heartjnl-2015-308514
Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE et al (2013) Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 72(12):1989–1994. doi:10.1136/annrheumdis-2012-202408
Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL (2003) Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48(12):3532–3537. doi:10.1002/art.11480
Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL (2003) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48(12):3522–3531. doi:10.1002/art.11353
Chatterjee S, Flamm SD, Tan CD, Rodriguez ER (2014) Clinical diagnosis and management of large vessel vasculitis: giant cell arteritis. Curr Cardiol Rep 16(7):498. doi:10.1007/s11886-014-0498-z
Daumas A, Rossi P, Bernard-Guervilly F, Frances Y, Berbis J, Durand JM et al (2014) Clinical, laboratory, radiological features, and outcome in 26 patients with aortic involvement amongst a case series of 63 patients with giant cell arteritis. Rev Med Interne 35(1):4–15. doi:10.1016/j.revmed.2013.06.007
Espitia O, Agard C (2013) Aortitis in giant cell arteritis and its complications. Rev Med Interne 34(7):412–420. doi:10.1016/j.revmed.2013.02.026
Weyand CM, Goronzy JJ (1999) Arterial wall injury in giant cell arteritis. Arthritis Rheum 42(5):844–853
Dasgupta B, Borg FA, Hassan N, Alexander L, Barraclough K, Bourke B et al (2010) BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 49(8):1594–1597. doi:10.1093/rheumatology/keq039a
Kermani TA, Warrington KJ, Crowson CS, Hunder GG, Ytterberg SR, Gabriel SE et al (2016) Predictors of dissection in aortic aneurysms from giant cell arteritis. J Clin Rheumatol 22(4):184–187. doi:10.1097/RHU.0000000000000381
Berti A, Campochiaro C, Cavalli G, Pepe G, Praderio L, Sabbadini MG et al (2015) Giant cell arteritis restricted to the limb arteries: an overlooked clinical entity. Autoimmun Rev 14(4):352–357. doi:10.1016/j.autrev.2014.12.005
Cullen JF (2009) Temporal arteritis 50 years on. Br J Ophthalmol 93(6):833–834
Freddo T, Price M, Kase C, Goldstein MP (1999) Myocardial infarction and coronary artery involvement in giant cell arteritis. Optom Vis Sci 76(1):14–18
Kimura T, Komura M, Okubo Y (2012) Atypical giant cell arteritis predominantly involving intramural coronary arteries: a case showing refractory dialysis-related hypotension. Heart Vessels 27(2):216–220. doi:10.1007/s00380-011-0158-9
Couturier B, Huyge V, Soyfoo MS (2011) Pericarditis revealing large vessel vasculitis. ISRN Rheumatol 2011:648703
Ruiz-Laiglesia FJ, Garces-Ayerbe MA, Ruiz-Olivares E, Torrubia-Perez CB (2000) Small-vessel vasculitis in granulomatous giant cell arteritis. Arch Intern Med 160(10):1537–1538
Imran TF, Helfgott S (2015) Respiratory and otolaryngologic manifestations of giant cell arteritis. Clin Exp Rheumatol 33(2 Suppl 89):S-164–S-170
Olopade CO, Sekosan M, Schraufnagel DE (1997) Giant cell arteritis manifesting as chronic cough and fever of unknown origin. Mayo Clin Proc 72(11):1048–1050. doi:10.1016/S0025-6196(11)63545-3
Lee S, Childerhouse A, Moss K (2011) Gastrointestinal symptoms and granulomatous vasculitis involving the liver in giant cell arteritis: a case report and review of the literature. Rheumatology (Oxford) 50(12):2316–2317. doi:10.1093/rheumatology/ker278
Mecklenburg I, Brumberger V, Burchardi C, Rademacher A, Pfeifer KJ, Folwaczny C (2006) Hepatic involvement in a patient with giant cell arteritis. Dig Dis Sci 51(1):39–40. doi:10.1007/s10620-006-3081-7
Papaioannou CC, Hunder GG, Lie JT (1979) Vasculitis of the gallbladder in a 70-year-old man with giant cell (temporal) arteritis. J Rheumatol 6(1):71–76
Burke AP, Sobin LH, Virmani R (1995) Localized vasculitis of the gastrointestinal tract. Am J Surg Pathol 19(3):338–349
Annamalai A, Francis ML, Ranatunga SK, Resch DS (2007) Giant cell arteritis presenting as small bowel infarction. J Gen Intern Med 22(1):140–144. doi:10.1007/s11606-006-0024-0
Scola CJ, Li C, Upchurch KS (2008) Mesenteric involvement in giant cell arteritis. An underrecognized complication? Analysis of a case series with clinicoanatomic correlation. Medicine (Baltimore) 87(1):45–51. doi:10.1097/MD.0b013e3181646118
Canton CG, Bernis C, Paraiso V, Barril G, Garcia A, Osorio C et al (1992) Renal failure in temporal arteritis. Am J Nephrol 12(5):380–383
Amarenco P, Amarenco G, Guillevin L, Roullet E, Sobann M, Baudrimont M et al (1988) Vesical neuropathy in systemic vasculitis: 3 cases. Ann Med Interne 139(3):183–185
Kadotani Y, Enoki Y, Itoi N, Kojima F, Kato G, Lee CJ (2010) Giant cell arteritis of the breast: a case report with a review of literatures. Breast Cancer 17(3):225–232. doi:10.1007/s12282-009-0120-1
Pradhan D, Amin RM, Jones MW, Surti U, Parwani AV (2016) Giant cell arteritis of the female genital tract with occult temporal arteritis and marginal zone lymphoma harboring novel 20q deletion: a case report and literature review. Int J Surg Pathol 24(1):78–84. doi:10.1177/1066896915605165
Bretal-Laranga M, Insua-Vilarino S, Blanco-Rodriguez J, Caamano-Freire M, Mera-Varela A, Lamas-Cedron P (1995) Giant cell arteritis limited to the prostate. J Rheumatol 22(3):566–568
Sundaram S, Smith DH (2001) Giant cell arteritis mimicking a testicular tumour. Rheumatol Int 20(5):215–216
Tsuji T, Sawabe M (1993) Giant-cell (temporal) arteritis following a bypass operation for cerebral infarction. J Dermatol 20(3):151–158
Nir-Paz R, Gross A, Chajek-Shaul T (2002) Reduction of jaw opening (trismus) in giant cell arteritis. Ann Rheum Dis 61(9):832–833
Carlson JA, Chen K-R (2007) Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol 29(1):32–43
Maidana DE, Munoz S, Acebes X, Llatjos R, Jucgla A, Alvarez A (2011) Giant cell arteritis presenting as scalp necrosis. Sci World J 11:1313–1315
Akram Q, Knight S, Saravanan R (2015) Bilateral scalp necrosis as a rare but devastating complication of giant cell arteritis. Clin Rheumatol 34(1):185–187. doi:10.1007/s10067-014-2792-y
Gibson LE (1990) Granulomatous vasculitides and the skin. Dermatol Clin 8(2):335–345
Caselli RJ, Daube JR, Hunder GG, Whisnant JP (1988) Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology 38(5):685–689
Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33(8):1122–1128
Grayson PC (2015) Lumpers and splitters: ongoing issues in the classification of large vessel vasculitis. J Rheumatol 42(2):149–151. doi:10.3899/jrheum.141376
Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 47(1):96–101. doi:10.1093/rheumatology/kem322
Aschwanden M, Kesten F, Stern M, Thalhammer C, Walker UA, Tyndall A et al (2010) Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis 69(7):1356–1359. doi:10.1136/ard.2009.122135
Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, Espigol-Frigole G, Tavera-Bahillo I, Butjosa M et al (2012) Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 71(7):1170–1176. doi:10.1136/annrheumdis-2011-200865
Ghinoi A, Pipitone N, Nicolini A, Boiardi L, Silingardi M, Germano G et al (2012) Large-vessel involvement in recent-onset giant cell arteritis: a case–control colour-Doppler sonography study. Rheumatology (Oxford) 51(4):730–734. doi:10.1093/rheumatology/ker329
Espitia O, Neel A, Leux C, Connault J, Espitia-Thibault A, Ponge T et al (2012) Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with longterm followup. J Rheumatol 39(11):2157–2162. doi:10.3899/jrheum.120511
Gonzalez-Gay MA, Pina T (2015) Giant cell arteritis and polymyalgia rheumatica: an update. Curr Rheumatol Rep 17(2):6. doi:10.1007/s11926-014-0480-1
Murchison AP, Gilbert ME, Bilyk JR, Eagle RC Jr, Pueyo V, Sergott RC et al (2012) Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol 154(4):722–729. doi:10.1016/j.ajo.2012.03.045
Heathcote JG (1999) Update in pathology: temporal arteritis and its ocular manifestations. Can J Ophthalmol 34(2):63–68
Murchison AP, Bilyk JR (2012) Brow ptosis after temporal artery biopsy: incidence and associations. Ophthalmology 119(12):2637–2642. doi:10.1016/j.ophtha.2012.07.020
Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL et al (2012) Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41(6):866–871. doi:10.1016/j.semarthrit.2011.10.005
Laria A, Zoli A, Bocci M, Castri F, Federico F, Ferraccioli GF (2012) Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein. Clin Rheumatol 31(9):1389–1393. doi:10.1007/s10067-012-2031-3
Zweegman S, Makkink B, Stehouwer CD (1993) Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Neth J Med 42(3–4):128–131
Kermani TA, Warrington KJ, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA et al (2015) Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study. J Rheumatol 42(7):1213–1217. doi:10.3899/jrheum.141347
Miller A, Green M, Robinson D (1983) Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) 286(6361):266
Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W et al (2006) Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113(10):1842–1845. doi:10.1016/j.ophtha.2006.05.020
Walvick MD, Walvick MP (2011) Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy. Ophthalmology 118(6):1201–1204. doi:10.1016/j.ophtha.2010.10.002
Hayreh SS, Podhajsky PA, Raman R, Zimmerman B (1997) Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 123(3):285–296
Khan A, Dasgupta B (2015) Imaging in giant cell arteritis. Curr Rheumatol Rep 17(8):52. doi:10.1007/s11926-015-0527-y
Investigators T (2009) Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL). In: Oxford Uo (ed), National Institute for Health Research.
Liu GT, Glaser JS, Schatz NJ, Smith JL (1994) Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 101(11):1779–1785
Proven A, Gabriel SE, Orces C, O’Fallon WM, Hunder GG (2003) Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 49(5):703–708. doi:10.1002/art.11388
Dunstan E, Lester SL, Rischmueller M, Dodd T, Black R, Ahern M et al (2014) Epidemiology of biopsy-proven giant cell arteritis in South Australia. Intern Med J 44(1):32–39. doi:10.1111/imj.12293
Acknowledgments
This work was supported by funding from the Australian National Health and Medical Research Council (NHMRC). CERA receives Operational Infrastructure Support from the Victorian Government. EDS is supported by an NHMRC postgraduate scholarship, and AWH is supported by an NHMRC Peter Doherty Fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No author has any competing interests related to this research. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
Information about participants
Additional informed consent was obtained from all individual participants for whom identifying information is included in this article (figures).
Rights and permissions
About this article
Cite this article
De Smit, E., O’Sullivan, E., Mackey, D.A. et al. Giant cell arteritis: ophthalmic manifestations of a systemic disease. Graefes Arch Clin Exp Ophthalmol 254, 2291–2306 (2016). https://doi.org/10.1007/s00417-016-3434-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3434-7